Arquivos brasileiros de oftalmologia最新文献

Purpose: This cross-sectional study compared best-corrected visual acuity obtained using Cloudscaper symbols, a novel optotype developed according to ETDRS specifications for children's virtual screening, with that obtained using LEA symbols.

Methods: A total of 560 children aged 3-16 yr underwent visual acuity test with both Cloudscaper symbols and LS. The test application was standardized using the EyeSpy algorithm. Additionally, 147 participants were tested with the standard Snellen E paper chart. Paired t tests were performed to assess the clinical significance of logMAR visual acuity differences.

Results: The mean logMAR visual acuity with LEA symbols was 0.12 (standard deviation [SD]=0.18; range, -0.10 to 0.80), while with Cloudscaper symbols it was 0.18 (SD=0.19; range, -0.10 to 0.80). The mean difference between Cloudscaper symbols and LEA symbols was 0.099 logMAR (approximately 0.5 optotypes; SD=0.08; range, 0.0-0.14; p<0.0001). Cloudscaper symbols slightly underestimated visual acuity compared to LEA symbols. Visual acuity measured by both methods was highly correlated (Spearman's r=0.74, p<0.0001). The mean visual acuity difference between Cloudscaper symbols and the Snellen E chart was 0.0045 (p=0.805; 95% confidence interval [95% CI]), whereas the difference between LEA symbols and Snellen E was 0.0883 (p<0.001; 95% CI).

Conclusions: Cloudscaper symbols provide a reliable tool for visual screening in children. Although they slightly underestimate visual acuity compared to LEA symbols - a finding also reported when comparing ETDRS letters with LEA symbols - Cloudscaper symbols show strong agreement with Snellen E chart measurements. This suggests that Cloudscaper symbols allow precise visual acuity assessment comparable to the gold standard.

Purpose: This pilot study evaluated the diagnostic accuracy of a deep learning model for detecting pterygium in anterior segment photographs taken using smartphones in the Brazilian Amazon. The model's performance was benchmarked against assessments made by experienced ophthalmologists, considered the clinical gold standard.

Methods: In this cross-sectional study, 38 participants (76 eyes) from Barcelos, Brazil, were enrolled. Trained nonmedical health workers captured high-resolution anterior segment images using smartphones. These images were analyzed using a deep learning model based on the MobileNet-V2 convolutional neural network. Diagnostic metrics-including sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve-were calculated and compared with the ophthalmologists' evaluations.

Results: The deep learning model achieved a sensitivity of 91.43%, specificity of 90.24%, positive predictive value of 88.46%, negative predictive value of 92.79%, and an area under the curve of 0.91. Logistic regression revealed no statistically significant association between pterygium and demographic variables such as age or gender.

Conclusions: The deep learning model demonstrated high diagnostic performance in identifying pterygium in a remote Amazonian population. These preliminary findings support the potential use of artificial intelligence-based tools to facilitate early detection and screening in underserved regions, thereby enhancing access to ophthalmic care.

The advantages and disadvantages of using perioperative subconjunctival steroid injections in dropless cataract surgery continue to be debated. A systematic review of PubMed, EMBASE, and the Cochrane Central database identified five studies-two randomized controlled trials and three non-randomized studies-encompassing 70,751 eyes. Among these, 12,319 eyes (17.4%) received subconjunctival steroid injections, while 58,432 eyes (82.6%) were managed with topical steroids. The Cochrane Collaboration's RoB 2 tool was applied for bias assessments in randomized controlled trials, and heterogeneity was assessed using the I² statistics. No statistically significant differences were found between the two groups regarding macular edema (p=0.249), visual acuity (p=0.73), or laser flare count (p=0.45). Both subconjunctival injections and topical steroids demonstrated comparable efficacy and safety in controlling postoperative inflammation after cataract surgery. Additional research is warranted to validate these conclusions.

Purpose: To examine how ophthalmological features, screen exposure duration, and break habits among office employees affect ocular surface parameters.

Methods: This single-center cross-sectional study involved two assessments on the same day: one before and one after a visual display terminal task. During the initial assessment, information on screen use was gathered, and refractive error, anterior segment examination, tear breakup time, and Schirmer test measurements were conducted. Participants tracked their screen usage and break durations throughout the day. At the end of the workday, tear breakup time and Schirmer I tests were repeated. Baseline and follow-up results were compared, and regression analysis was performed to identify factors linked to tear breakup time reduction.

Results: The study enrolled 60 female office employees. Their mean screen time was 269.26 ± 70.21 min, with an average break duration of 151.93 ± 46.24 min. Tear breakup time at the second assessment (6.38 ± 2.70) was significantly lower than at baseline (8.62 ± 2.73) (p<0.001), whereas Schirmer test scores showed no significant change (p>0.05). Tear breakup time reduction was noted in 54 participants (90.0%), with a significant association between tear breakup time decrease percentage and screen exposure (p=0.001, r=0.463). Regression analysis showed that uncorrected or undercorrected refractive error was an independent risk factor for a ≥30% tear breakup time reduction, while taking more frequent short breaks (<15 min) acted as a protective factor.

Conclusions: Taking more frequent short breaks (<15 min) and correcting refractive errors help prevent intra-day tear breakup time decline during visual display terminal use. Structuring breaks to support tear film stability is advisable for occupations that require regular visual display terminal tasks.

Purpose: Using advanced imaging techniques, this study aimed to evaluate corneal stability, epithelial remodeling, and tear film changes over a one-year period in first-time soft-contact lens wearers.

Methods: A retrospective study was conducted on 100 eyes of 50 first-time daily soft-contact lens users aged 21-65 years with no prior rigid gas-permeable lens wear. The Sirius Scheimpflug imaging system was used to assess corneal topography, epithelial thickness, and non-invasive tear break-up time at baseline, 3, 6, and 12 months. Corneal warpage was evaluated using symmetry indices and Baiocchi Calossi Versaci indices. We performed statistical analysis using repeated-measures analyses of variance with Greenhouse-Geisser correction.

Results: The mean baseline central corneal thickness was 537.83 (±7.92) µm, with no significant thinning after one year. The average simulated keratometry values remained stable, indicating no progressive corneal steepening or flattening. There were no significant changes in warpage indices over time, suggesting corneal shape preservation. Higher-order aberrations (coma, trefoil, and spherical aberrations) and non-invasive tear break-up time remained unchanged throughout the study period.

Conclusions: Modern silicone hydrogel soft-contact lenses do not induce significant corneal warpage, epithelial remodeling, or optical aberrations over a one-year period. We found that corneal morphology and tear film stability were preserved, supporting the safety of soft-contact lens use. These findings provide clinically relevant insights into the long-term impact of contact lens wear. They may facilitate improved lens fitting strategies and preope rative refractive surgery assessments.

Purpose: To report the surgical outcomes of patients with primary congenital glaucoma who underwent gonioscopy-assisted transluminal trabeculotomy.

Methods: This retrospective, noncomparative, interventional study included consecutive patients with primary congenital glaucoma with uncontrolled intraocular pressure undergoing gonioscopy-assisted transluminal trabeculotomy between January 2017 and January 2020. The included participants were followed up for at least 24 months, and only one surgeon performed all the procedures. The number of glaucoma medications, pre- and postoperative intraocular pressure, treatment extension (in quadrants), surgical complications, and any associated events or interventions were documented.

Results: This study included 13 eyes from 10 patients (mean age, 4.5 ± 3.2 years; range, 3 months to 10 years). After a 24-month follow-up, the mean intraocular pressure significantly decreased from 26.1 ± 3.7 to 11.8 ± 2.5 mmHg (p<0.001). The mean number of glaucoma medications was reduced from 3.3 ± 0.5 to 0.85 ± 1.0 (p<0.001). At the end of the follow-up interval, all eyes (13 out of 13) had an intraocular pressure between 7 and 15 mmHg. In 11 of 13 eyes (84.6%), gonioscopy-assisted transluminal trabeculotomy was performed in all quadrants (360º). The most frequent postoperative complication was transitory (self-limited) hyphema (7 out of 13 eyes [53.8%]). No sight-threatening adverse events occurred during the entire follow-up period.

Conclusions: The 2-year follow-up results indicated gonioscopy-assisted transluminal trabeculotomy as an efficient and safe option for primary congenital glaucoma treatment with minimal postoperative complications.

Purpose: Standard intravitreal medication dosages are based on an assumed vitreous cavity volume of 4.0-4.5 mL. However, individual variations in vitreous cavity volume may influence both the efficacy and safety of these medications. This study proposes dosage adjustments for intravitreal medications and gases according to axial length and the corresponding vitreous cavity volume.

Methods: This descriptive study employed reference guidelines that use axial length to estimate the Axial Length-based Volume of the Vitrectomized Space and the Vitreous Volume EXact table for determining dose adjustments across varying eye sizes. Small eyes (axial length 19-22 mm) have an average vitreous cavity volume of 3.5 mL at an axial length of 20.5 mm; standard-sized eyes (22-25 mm) have 4.8 mL at 23.5 mm; large eyes (25-28 mm) have 6.4 mL at 26.5 mm; and extra-large eyes (28-32 mm) have 8.4 mL at 29.5 mm. The medications considered included anti-infectives, anti-VEGFs, complement inhibitors, recombinant proteases, chemotherapy agents, corticosteroids, and medical gases.

Results: Analysis of intravitreal drug concentrations relative to vitreous cavity volume demonstrated notable variability when a standard dose was administered. Small eyes received about 135% of the concentration intended for a standard-sized eye; large eyes received around 75%; and extra-large eyes received under 60%. The recommended dose adjustments are as follows: for small eyes, administer 70-80% of the standard dose; for large eyes, 130-140%; and for extra-large eyes, 170-180%.

Conclusions: Tailoring intravitreal drug and gas dosages according to axial length and vitreous cavity volume may enhance intraocular drug distribution, potentially improving both safety and therapeutic outcomes.